Universe Pharmaceuticals INC
UPC
$4.91
-$0.21-4.10%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 133.39% | 0.00% | -123.36% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -4.82% | 0.00% | -0.88% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -192.84% | 0.00% | 4,067.42% | 0.00% |
| Change in Net Operating Assets | 0.00% | -114.68% | 0.00% | -139.24% | 0.00% |
| Cash from Operations | 0.00% | -191.28% | 0.00% | 34.01% | 0.00% |
| Capital Expenditure | 0.00% | -163.61% | 0.00% | -55.05% | 0.00% |
| Sale of Property, Plant, and Equipment | 0.00% | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00% | -- | -- | -- | -- |
| Cash from Investing | 0.00% | -334.32% | 0.00% | -55.05% | 0.00% |
| Total Debt Issued | 0.00% | 2.10% | 0.00% | 193.76% | 0.00% |
| Total Debt Repaid | 0.00% | -300.13% | 0.00% | 81.23% | 0.00% |
| Issuance of Common Stock | 0.00% | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | 359.58% | 0.00% | 274.78% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 1,972.41% | 0.00% | 101.23% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | 477.01% | 0.00% | 146.63% | 0.00% |